Axonics, Inc. - Common Stock (AXNX)
70.98
0.00 (0.00%)
Axonics Inc is a medical technology company that specializes in the development and commercialization of innovative solutions for the treatment of urinary and bowel dysfunction
The company focuses on neurostimulation therapy, offering sacral neuromodulation devices designed to improve the quality of life for patients suffering from conditions such as overactive bladder, urinary incontinence, and fecal incontinence. Through its commitment to advanced medical technology and patient-centered care, Axonics aims to provide effective and minimally invasive treatment options that enhance the overall health and well-being of individuals affected by these disorders.
| Date | Open | High | Low | Close | Volume | Adjusted Close |
|---|---|---|---|---|---|---|
| 11/14/2024 | 70.45 | 0.00 | 70.98 | 70.98 | 0 | 70.98 |
| 11/13/2024 | 70.57 | 70.57 | 70.45 | 70.45 | 245,214 | 70.45 |
| 11/12/2024 | 70.44 | 70.58 | 70.44 | 70.49 | 353,818 | 70.49 |
| 11/11/2024 | 70.43 | 70.58 | 70.40 | 70.48 | 501,626 | 70.48 |
| 11/08/2024 | 70.48 | 70.50 | 70.40 | 70.42 | 233,837 | 70.42 |
| 11/07/2024 | 70.41 | 70.48 | 70.36 | 70.45 | 438,412 | 70.45 |
| 11/06/2024 | 70.46 | 70.75 | 70.39 | 70.48 | 735,902 | 70.48 |
| 11/05/2024 | 70.36 | 70.43 | 70.28 | 70.31 | 528,699 | 70.31 |
| 11/04/2024 | 70.37 | 70.48 | 70.33 | 70.38 | 289,027 | 70.38 |
| 11/01/2024 | 70.45 | 70.45 | 70.29 | 70.37 | 506,435 | 70.37 |
| 10/31/2024 | 70.34 | 70.44 | 70.15 | 70.30 | 279,984 | 70.30 |